Medix Nivolumab Export Data — India (DGFT 2022–2026)

Name: Medix Nivolumab Export Records India — #9 Exporter, 5 Shipments, $27.0K FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-04-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Nivolumab

India Pharmaceutical Trade Intelligence

$2.3M23 Suppliers13 CountriesHS 30049099

ExportsIndia → SINGAPORE46.0%India → RUSSIA33.9%

ImportsUNITED STATES → India$48.1B SWITZERLAND → India$15.1M

Medix — Nivolumab Exporter #9 | $27.0K Trade Value | TransData Nexus | TransData Nexus

Medix — Nivolumab Exporter Profile

Indian Pharmaceutical Exporter · #9 for Nivolumab · $27.0K export value · DGFT Verified

Medix is the #9 Indian exporter of Nivolumab with $27.0K in export value and 5 verified shipments. Medix holds a 1.2% market share in Nivolumab exports across 1 countries.

Medix — Nivolumab Export Profile: Buyers & Destinations

Medix Nivolumab export treemap — buyers and destination countries | TransData Nexus

Where Does India Export Nivolumab?

Country	Value	Shipments	Share
SINGAPORE	$800.0K	16	48.2%
RUSSIA	$400.0K	8	24.1%
BRAZIL	$280.5K	59	16.9%
SEYCHELLES	$56.6K	6	3.4%

Who Are the Top Buyers of Nivolumab from India?

Buyer	Country	Value	Orders
COREX LLC	RUSSIA	$400.0K	8
ALMAC PHARMACEUTICAL SERVICES PTE LIMITED	SINGAPORE	$100.0K	2
AS PER INVOICE	BRAZIL	$72.9K	7
STATE TRADING ORGANIZATION PLC	MALDIVES	$32.3K	6
JAIR CARLOS DE ARAUJO	BRAZIL	$30.5K	4
HEALTH CARE AGENCY	SEYCHELLES	$21.7K	2
INDIRA GANDHI MEMORIAL HOSPITAL	MALDIVES	$12.0K	5
FRANCISCO EUDES DA SILVA	BRAZIL	$11.8K	2
ELIZETE DE OLIVEIRA DA SILVA	BRAZIL	$11.8K	4
INVOICE RAISED TO SEYCHELLES	SEYCHELLES	$11.8K	2

India's Nivolumab is purchased by 47 buyers worldwide. The top buyer is COREX LLC (RUSSIA), followed by ALMAC PHARMACEUTICAL SERVICES PTE LIMITED and AS PER INVOICE.

How Does Medix Compare to Nearest Nivolumab Exporters?

Exporters ranked immediately above and below #9 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
7	VEA IMPEX I PRIVATE LIMITED	$27.9K	4	3	$7.0K
8	SPECIALITY MEDICINES PRIVATE LIMITED	$27.8K	6	1	$4.6K
9	MEDIX ★	$27.0K	5	1	$5.4K
10	NU HOSPITALS PRIVATE LIMITED	$12.0K	5	1	$2.4K

Medix ranks #9 among 23 Indian Nivolumab exporters. Average shipment value of $5.4K compared to the market average of $41.1K. The closest competitors by value are VEA IMPEX I PRIVATE LIMITED and SPECIALITY MEDICINES PRIVATE LIMITED.

Which Indian Ports Ship Nivolumab Exports?

Port	Shipments	% Share
AHEMDABAD AIR ACC (INAMD4)	38	26.4%
SAHAR AIR	27	18.8%
AHEMDABAD AIR	15	10.4%
HYDERABAD AIR	11	7.6%
SAHAR AIR CARGO ACC (INBOM4)	11	7.6%
Ahmedabad Air	8	5.6%
CHENNAI AIR CARGO ACC (INMAA4)	5	3.5%
BANGALORE ACC (INBLR4)	5	3.5%

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Nivolumab shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: Medix matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 13+ countries, 47+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Nivolumab

Nivolumab

Medix — Nivolumab Exporter Profile

Medix — Nivolumab Export Profile: Buyers & Destinations

Where Does India Export Nivolumab?

Who Are the Top Buyers of Nivolumab from India?

What Is India's Total Nivolumab Export Value and How Much Does Medix Contribute?

What Is the Average Shipment Value for Medix's Nivolumab Exports?

How Does Medix Compare to Other Indian Nivolumab Exporters?

Regulatory Requirements: Exporting Nivolumab to Key Markets

Brazil — ANVISA

How Does Medix Compare to Nearest Nivolumab Exporters?

Which Indian Ports Ship Nivolumab Exports?

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Nivolumab Export Data from Medix

Nivolumab Stats

Related Analysis

Need Detailed Export Data?

Data Source